{"transactions":[{"id":2819745,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":142008,"kind":"person","name":"Arcudi III Louis J","position":1,"cik":"0001419350","reported_name":"Arcudi III Louis J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T17:18:10.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. Twenty-five percent (25%) of the shares subject to this option shall vest on February 1, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. However, all such options, to the extent outstanding immediately prior to a Change in Control (as defined in the 2019 Equity Incentive Plan), will be (or will be deemed to have been) fully vested and exercisable as of immediately prior to such Change in Control."}],"balance_after":400000,"derivative":{"exercise_price":2.06,"expiration_date":"2031-02-25","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001544227-21-000010","document":"wf-form4_161472344947814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419350/000154422721000010/wf-form4_161472344947814.xml","form_type":"4"}},{"id":3133552,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":142008,"kind":"person","name":"Arcudi III Louis J","position":1,"cik":"0001419350","reported_name":"Arcudi III Louis J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-05-27T21:45:34.000Z","date":"2020-05-25","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the shares subject to this option shall vest on the earlier of: (i) December 31, 2020 or (ii) the Board's approval of the achievement of certain performance criteria, and one twelfth (1/12th) of the\nremaining shares subject to this option shall vest in equal monthly installments thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each such date."}],"balance_after":80000,"derivative":{"exercise_price":2,"expiration_date":"2030-05-24","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-20-032489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419350/000120919120032489/doc4.xml","form_type":"4"}},{"id":3291372,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":142008,"kind":"person","name":"Arcudi III Louis J","position":1,"cik":"0001419350","reported_name":"Arcudi III Louis J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-04T16:29:26.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":71250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option shall vest on January 7, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":71250,"derivative":{"exercise_price":7.94,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":71250},"source":{"system":"sec-edgar","filing":"0001209191-20-006345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419350/000120919120006345/doc4.xml","form_type":"4"}},{"id":3481225,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":142008,"kind":"person","name":"Arcudi III Louis J","position":1,"cik":"0001419350","reported_name":"Arcudi III Louis J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-06-21T16:33:05.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option shall vest on June 20, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":25000,"derivative":{"exercise_price":11.59,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-038475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419350/000120919119038475/doc4.xml","form_type":"4"}},{"id":3692889,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":142008,"kind":"person","name":"Arcudi III Louis J","position":1,"cik":"0001419350","reported_name":"Arcudi III Louis J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-17T16:43:48.000Z","date":"2019-01-15","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option shall vest on January 15, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":50000,"derivative":{"exercise_price":8.8,"expiration_date":"2029-01-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-004226","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419350/000120919119004226/doc4.xml","form_type":"4"}},{"id":3735502,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":142008,"kind":"person","name":"Arcudi III Louis J","position":1,"cik":"0001419350","reported_name":"Arcudi III Louis J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-12-11T19:35:13.000Z","date":"2018-12-07","kind":"grant","acquired":true,"shares":74400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option shall vest on November 1, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":74400,"derivative":{"exercise_price":10.395,"expiration_date":"2028-12-06","underlying":"Common Stock","underlying_shares":74400},"source":{"system":"sec-edgar","filing":"0001209191-18-062105","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1419350/000120919118062105/doc4.xml","form_type":"4"}},{"id":3843945,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":142008,"kind":"person","name":"Arcudi III Louis J","position":1,"cik":"0001419350","reported_name":"Arcudi III Louis J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-08-15T16:32:10.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Company's 2013 Stock Incentive Plan. The option vests with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in twelve equal quarterly installments following the first anniversary of the date of grant."}],"balance_after":32500,"derivative":{"exercise_price":7.39,"expiration_date":"2028-08-13","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001104659-18-052291","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000110465918052291/a4.xml","form_type":"4"}},{"id":4106073,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":142008,"kind":"person","name":"Arcudi III Louis J","position":1,"cik":"0001419350","reported_name":"Arcudi III Louis J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-01-05T16:20:09.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":270000,"price":2.24,"value":604800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Company's 2013 Stock Incentive Plan. The options vest with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in twelve equal quarterly installments following the first anniversary of the date of grant."}],"balance_after":270000,"derivative":{"exercise_price":2.24,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001179110-18-000587","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911018000587/edgar.xml","form_type":"4"}},{"id":4496991,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":142008,"kind":"person","name":"Arcudi III Louis J","position":1,"cik":"0001419350","reported_name":"Arcudi III Louis J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2017-01-06T16:24:19.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Company's 2013 Stock Incentive Plan. The options vest with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in twelve equal quarterly installments following the first anniversary of the date of grant."}],"balance_after":185000,"derivative":{"exercise_price":1.59,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001179110-17-000646","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911017000646/edgar.xml","form_type":"4"}}]}